Completed PHASE1 INTERVENTIONAL 3-arm NCT01023945

A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus

A Phase 1, Randomized, Double-blind, Placebo Controlled, Monotherapy Study to Assess the Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus

Sponsor: Astellas Pharma Inc

Conditions Type 2 Diabetes Mellitus

Interventions ASP1941 Placebo

Updated 8 times since 2017 Last updated: Nov 8, 2024 Started: Nov 7, 2009 Primary completion: Mar 26, 2010 Completion: Mar 26, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Type 2 Diabetes Mellitus and is currently completed. Astellas Pharma Inc leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Dec 2024 — Present [monthly]

Completed PHASE1
Sep 2024 — Dec 2024 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Sep 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 3 earlier versions

Jun 2018 — Sep 2018 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Astellas Pharma Inc

Data source: Astellas Pharma Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kantou, Japan